SecBot SecBot
144 ·Filed Aug 13, 2026

DYN

Dyne Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001972481-26-000259
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

The filing is a routine RSU-cover-to-tax sale by an officer with no discretionary signal. Monitor for any subsequent Form 4 filings to confirm execution, but no trading action is warranted based on this notice alone.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$25.70
T+0 close · Aug 13, 2026 · via day close
Latest settled
−26.96%
T+60 · $18.77
Vs SPY
−24.16%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 14 $25.70entry
  2. T+1 · 3mo ago +1.75%α +2.22% · $26.15
  3. T+5 · 3mo ago +1.56%α +2.92% · $26.10
  4. T+20 · 2mo ago −27.94%α −25.95% · $18.52
  5. T+60 · 8d ago −26.96%α −24.16% · $18.77
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Erick Lucera, an officer of Dyne Therapeutics, filed a Form 144 on August 13, 2026, indicating intent to sell 1,797 shares of common stock with an approximate market value of $47,226. The shares were acquired via restricted stock unit vesting on August 12, 2026, and the sale is for equity compensation-related tax obligations. Given the small size relative to the company's $4.9B market cap and the routine nature of RSU-based sales, this filing is neutral.

Key Facts

  • Officer Erick Lucera filed Form 144 to sell 1,797 shares of Dyne Therapeutics common stock.
  • Estimated sale value is approximately $47,226 based on filing date.
  • Shares were acquired via restricted stock unit vesting on August 12, 2026.
  • Sale is for equity compensation-related purposes, not a discretionary open-market exit.
  • The proposed sale represents a negligible fraction of the company's $4.9B market capitalization.

Financial Impact

Proposed sale of 1,797 shares worth ~$47,226, immaterial relative to $4.9B market cap.

dilution

Risk Factors

  • Form 144 is an intent to sell, the sale may not be executed.
  • No material risk to the company or stock from this de minimis insider sale.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001972481-26-000259
Document: 0001972481-26-000259-index.html0001972481-26-000259
Document: 0001972481-26-000259.txt0001972481-26-000259

Track record

54 reports on DYN

Performance horizon

12 of 16 bullish or bearish reports moved the stock their way by T+20. Best: +46.36% at T+60 after the May 20, 2026 report. 15 of 16 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $16.77 Now $16.70 −0.39% settles Dec 15
  2. Nov 13, 20263d ago 144 Neutral 2/10 Entry $17.16 Now $16.70 −2.68% settles Dec 15
  3. Nov 13, 20263d ago 144 Neutral 2/10 Entry $17.16 Now $16.70 −2.68% settles Dec 15
  4. Nov 5, 202611d ago 8-K Neutral 5/10 No price data
  5. Nov 5, 202611d ago Press Release Neutral 5/10 Entry $17.36 Now $16.70 −3.80% settles Dec 4
  6. Oct 29, 202618d ago Institutional Cluster Neutral 2/10 Entry $17.04 Now $16.70 −2.00% settles Nov 27
  7. Oct 22, 202625d ago Press Release Neutral 2/10 Entry $15.62 Now $16.70 +6.91% settles Nov 20
  8. Oct 12, 20265w ago Institutional Cluster Mixed 4/10 Entry $15.96 to $18.62 Now $16.70 +4.64% ▲ +16.67% +19.93% vs SPY
  9. Sep 29, 20266w ago Press Release Bullish 7/10 Entry $16.11 to $16.94 Now $16.70 +3.66% ▲ +5.15% +4.23% vs SPY
  10. Sep 8, 20269w ago Insider Cluster Neutral 3/10 Entry $19.19 to $15.97 Now $16.70 −12.98% ▼ −16.78% −18.72% vs SPY
Showing 10 of 54

US Market Status

Market Closed · Opens Wed (11h 3m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 13, 2026